Please Subscribe to get a daily link to Pat's blog via email


Your privacy is important to us. We will never spam you and keep your personal data secure.

Dr. Barlogie

Home/Tag:Dr. Barlogie
4 04, 2015

BREAKING NEWS: Myeloma pioneer may leave UAMS

Tags: , |26 Comments

Several Myeloma Institute for Research and Therapy (MIRT) patients have contacted me, concerned that world renowned myeloma specialist, Dr. Bart Barlogie, may be leaving UAMS in Little Rock. I’m having trouble getting a clear picture of what’s really happening. Apparently the split is contentious; not sure if he’s being forced out or asked to leave.

2 09, 2014

California reader needs your help

Tags: , |8 Comments

It has been a crazy busy day!  I spent the morning working with my landscape contractor.  Then the afternoon getting blood work, meeting with my local medical oncologist and undergoing radiation therapy.  Needless to say I'm wiped tonight! Our air conditioning conked out over the holiday weekend.  No parts available until today.  The good news

24 08, 2014

Proof multiple myeloma docs have personal lives, too

Tags: , , |5 Comments

Dr. Bart Barlogie is a myeloma legend.  Love him or hate him, his unbridled obsession for finding a multiple myeloma cure has been relentless. The father of Total Therapy, Dr. Barlogie has helped the University of Arkansas Medical School (UAMS) develop one of the world's foremost multiple myeloma treatment centers, known as the Myeloma Institute

11 09, 2013

Black Swan Research Initiative (Part Two)

Tags: , , , , , , , |19 Comments

With few exceptions, most myeloma specialists don't believe that our cancer can be cured using therapy options available today.  These exceptions include a small percentage (5-10%) of allogeneic (donor) transplant recipients, and possibly some low risk, Total Therapy grads from Arkansas.  Any others are considered outliers; rare exceptions that don't fit the norm. Five years

16 01, 2012

Monday morning homework

Tags: , , , , , , , |14 Comments

Last month I was featured in a Nature Magazine article about multiple myeloma and stem cell transplants: Stem cells: Transplants on trial By Elie Dolgin They included this handsome picture, too! Point of fact, the photo editors--located in England--flipped the captions of the two pictures I sent them.  The actual stem cell infusion pic was

19 01, 2011

Dr. Barlogie From UAMS: "Revlimid Does Not Cause Secondary Cancer."

Tags: , , , , , |0 Comments

There was a very large controversy last December at ASH in Orlando.  Two studies which followed long-term Revlimid users found they had an 8% risk of developing a form of Acute Myeloid Leukemia (AML).Revlimid is manufactured by Celgene Pharmaceuticals, a publicly traded company.  This news caused Celgene's stock to crash and rumors to explode in

8 08, 2010

Exciting New Multiple Myeloma Therapy Study Overview Published In Blood: Union Of Forces Advances Myeloma Care

Tags: , , , , , |2 Comments

While attending an International Myeloma Foundation (IMF) Patient and Family Seminar last fall in Minneapolis, I met an impressive, young myeloma doc and researcher on the rise, Mayo Clinic's Dr. Kieth Stewart.  I felt he had a very reasonable and balanced approach to myeloma therapy.  Here is a research paper the prestigious hematological publication, Blood,

18 06, 2010

High Risk Multiple Myeloma Research Studies Featured At ASCO

Tags: , , , |0 Comments

Yesterday I shared part of my conversation/interview with Dr. Ravi Vij, a multiple myeloma specialist with the University of Washington School of Medicine.  The conversation centered on the University of Arkansas Medical Center's intense research into classifying and treating high risk myeloma.Here is a link to the American Society of Clinical Oncology (ASCO) Data Base, connecting

17 06, 2010

University Of Arkansas Medical Center Pushes Advances In High Risk Multiple Myeloma Therapy

Tags: , , , , , , |4 Comments

Before we move on, I wanted to share some of Dr. Ravi Vij's thoughts about UAMS—the University of Arkansas Medical Center. Myeloma docs and researchers there have been developing an aggressive form of anti-myeloma treatment called Total Therapy (TT). Arkansas myeloma specialist, Dr. Barlogie, and other UAMS myeloma researchers are best known for helping newly